Skip to content
EN
DE
info@priavoid.com
+49 211 942 522 98
Toggle Navigation
About us
Technology
Pipeline
Working with us
Partnering & Investing
Careers
Media
News & Events
Press
Press Release
Categories
Press Release
8
News
11
Event
3
News, Press Release
Priavoid appoints CSO and CMO
Continue reading
News, Press Release
PRImus-AD: Recruitment for Phase II clinical trial of Alzheimer’s drug PRI-002 successfully completed
Continue reading
News, Press Release
Priavoid receives funding from the Alzheimer’s Association and the Rainwater Charitable Foundation to further develop its tau program
Continue reading
News, Press Release
New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study
Continue reading
News, Press Release
Priavoid and Research Center Jülich receive funding from The Michael J. Fox Foundation
Continue reading
News, Press Release
Priavoid closes financing round
Continue reading
1
2
Next
Page load link
